|
TRIM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62360003219675E-09 |
| Normal-vs-Stage2 |
5.84670001302356E-09 |
| Normal-vs-Stage3 |
1.80529999949108E-07 |
| Normal-vs-Stage4 |
2.68079999998783E-06 |
| Stage1-vs-Stage2 |
5.265800E-01 |
| Stage1-vs-Stage3 |
6.137400E-01 |
| Stage1-vs-Stage4 |
2.919200E-01 |
| Stage2-vs-Stage3 |
9.828800E-01 |
| Stage2-vs-Stage4 |
5.916600E-01 |
| Stage3-vs-Stage4 |
7.309200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63791202822949E-12 |
| Normal-vs-AfricanAmerican |
1.09660003300149E-09 |
| Normal-vs-Asian |
5.21150000931669E-09 |
| Caucasian-vs-AfricanAmerican |
7.521200E-01 |
| Caucasian-vs-Asian |
3.121800E-02 |
| AfricanAmerican-vs-Asian |
2.447800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.42440503836383E-11 |
| Male-vs-Female |
5.872200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55110368993405E-11 |
| Normal-vs-Extreme_Weight |
6.28790353118802E-11 |
| Normal-vs-Obese |
5.12250020179295E-10 |
| Normal-vs-Extreme_Obese |
2.19900000431039E-08 |
| Normal_Weight-vs-Extreme_Weight |
5.406000E-01 |
| Normal_Weight-vs-Obese |
1.223030E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.710400E-01 |
| Extreme_Weight-vs-Obese |
3.509800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.773400E-01 |
| Obese-vs-Extreme_Obese |
5.347400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.55419999998175E-07 |
| Normal-vs-Age(41-60Yrs) |
4.43867165245138E-13 |
| Normal-vs-Age(61-80Yrs) |
4.76285677564192E-14 |
| Normal-vs-Age(81-100Yrs) |
1.74059655577707E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.854200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.838600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.660400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.806200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.041300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.357600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.50270001892028E-09 |
| Normal-VS-Type2 PRCC |
9.99200722162641E-16 |
| Normal-VS-KIRP CIMP |
6.18900000137756E-08 |
| Normal-VS-Unclassified PRCC |
1.27960000040339E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.323400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.473200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.008600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.492800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.918000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.366800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07870054502735E-10 |
| Normal-vs-N1 |
1.36699995767486E-09 |
| Normal-vs-N2 |
2.164300E-03 |
| N0-vs-N1 |
9.539800E-01 |
| N0-vs-N2 |
6.720000E-01 |
| N1-vs-N2 |
6.499200E-01 |
|
|
